Pfizer could have vaccine data for children under five by end of 2021, CEO says

DMCA / Correction Notice
- Advertisement -

Pfizer may have data on COVID-19 vaccine efficacy for children under the age of five by the end of the year, CEO Albert Boerla said on Friday in a interview with nbc news,

- Advertisement -

why it matters: Omicron has expressed concern that young children are becoming vulnerable to the virus. Tshwane, the epicenter of South Africa’s Omicron outbreak, has seen high numbers of hospitalizations for children under the age of two over the past few weeks, although scientists have not confirmed the link to the variant, Reuters report,

What are they saying: “We have one study in 6 months to 2 year olds and then another group of 2 to 5 year olds,” said Bouerla. “Therefore [by] At the end of the year, early next year, we will know more when we see the figures.”

  • According to NBC News, Moderna is also testing its vaccine among children, though it’s not clear when the data will be available.

Noteworthy: US Food and Drug Administration 0n Friday authorized emergency use Eli Lilly’s COVID antibody therapy treatment for children under 12 years of age who test positive and are at risk for serious illness.


- Advertisement -

Stay on top - Get the daily news in your inbox

Recent Articles

Related Stories